Home

JOHN PETER MCLAUGHLIN

CIK 1277967 · CEO · last filed 2023-05-30

JOHN PETER MCLAUGHLIN is a CEO who has filed 43 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for LNSR, was dated May 30, 2023. Across all open-market trades the lifetime net is −$855.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $397.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$397.7K

Companies

6

Total Filings

43

Lifetime Open-Market Net

-$855.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LNSR Director 53,631 $5.82 $312.1K $0 5 2023-05-30
RMTI Director 136,974 $0.62 $85.6K $0 4 2021-06-22
PDL BIOPHARMA, INC. (PDLI) Delisted CEO 477,934 — — -$855.8K 18 2020-12-22
Seagen Inc. (SGEN) Delisted Director 39,400 $228.74 $9.01M $0 10 2016-05-24
Adverum Biotechnologies, Inc. (AAVL) Delisted Director 23,613 — — $0 4 2016-02-17
ANESIVA, INC. (ANSV) Delisted Chief Executive Officer 118,826 — — $0 2 2008-02-08

Recent Filings

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-30 LNSR Grant (A) +9,288 $0 EDGAR
2022-05-27 LNSR Grant (A) +4,285 $0 EDGAR
2021-06-22 RMTI Grant (A) +50,000 $0 EDGAR
2021-05-20 LNSR Grant (A) — $0 EDGAR
2021-03-16 LNSR Grant (A) — $0 EDGAR
2021-02-02 LNSR Grant (A) — $0 EDGAR
2020-12-22 PDL BIOPHARMA, INC. (PDLI) Delisted Sell (S) −327,934 -$855.8K EDGAR
2020-08-24 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) +25,826 $0 EDGAR
2020-05-20 RMTI Grant (A) +51,800 $0 EDGAR
2020-01-31 RMTI Grant (A) +12,615 $0 EDGAR
Showing 1–10 of 43
Page 1 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.